Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 1
1998 2
1999 1
2001 1
2002 1
2003 3
2004 1
2005 6
2006 7
2007 8
2008 6
2009 6
2010 11
2011 10
2012 22
2013 22
2014 14
2015 14
2016 13
2017 12
2018 13
2019 18
2020 10
2021 16
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A, Erlewyn-Lajeunesse M, Martin S, Mäkelä M, Nell P, Pool V, Simpson N; Brighton Collaboration Anaphylaxis Working Group. Rüggeberg JU, et al. Among authors: khamesipour a. Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12. Vaccine. 2007. PMID: 17448577 No abstract available.
Case study for a vaccine against leishmaniasis.
Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Alvar J, et al. Among authors: khamesipour a. Vaccine. 2013 Apr 18;31 Suppl 2:B244-9. doi: 10.1016/j.vaccine.2012.11.080. Vaccine. 2013. PMID: 23598489 Review.
Potential biomarkers of immune protection in human leishmaniasis.
Rostami MN, Khamesipour A. Rostami MN, et al. Among authors: khamesipour a. Med Microbiol Immunol. 2021 Jun;210(2-3):81-100. doi: 10.1007/s00430-021-00703-8. Epub 2021 May 2. Med Microbiol Immunol. 2021. PMID: 33934238 Free PMC article. Review.
Liposomal adjuvant development for leishmaniasis vaccines.
Askarizadeh A, Jaafari MR, Khamesipour A, Badiee A. Askarizadeh A, et al. Among authors: khamesipour a. Ther Adv Vaccines. 2017 Aug;5(4-5):85-101. doi: 10.1177/2051013617741578. Epub 2017 Nov 15. Ther Adv Vaccines. 2017. PMID: 29201374 Free PMC article. Review.
Therapeutic vaccines for leishmaniasis.
Khamesipour A. Khamesipour A. Expert Opin Biol Ther. 2014 Nov;14(11):1641-9. doi: 10.1517/14712598.2014.945415. Epub 2014 Jul 31. Expert Opin Biol Ther. 2014. PMID: 25077737 Review.
Prioritizing polio.
Rath B, Ali M, Elemuwa C, Maurer W, Bouder F, Mworozi E, Diedrich S, Khamesipour A, Chitwood I, Kochhar S; Vienna Vaccine Safety Initiative. Rath B, et al. Among authors: khamesipour a. Expert Rev Vaccines. 2012 Dec;11(12):1389-92. doi: 10.1586/erv.12.128. Expert Rev Vaccines. 2012. PMID: 23252381 No abstract available.
Development of nano-carriers for Leishmania vaccine delivery.
Askarizadeh A, Badiee A, Khamesipour A. Askarizadeh A, et al. Among authors: khamesipour a. Expert Opin Drug Deliv. 2020 Feb;17(2):167-187. doi: 10.1080/17425247.2020.1713746. Epub 2020 Jan 14. Expert Opin Drug Deliv. 2020. PMID: 31914821 Review.
Introducing new vaccines in developing countries.
Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M; Vienna Vaccine Safety Initiative. Kochhar S, et al. Among authors: khamesipour a. Expert Rev Vaccines. 2013 Dec;12(12):1465-78. doi: 10.1586/14760584.2013.855612. Expert Rev Vaccines. 2013. PMID: 24195483 Review.
205 results